Published 6 January 2009, doi:10.1136/bmj.a3145
Cite this as: BMJ 2009;338:a3145

Letters

Trading laws and health foods

Lip service legislation

The first 150 words of the full text of this article appear below.

More than two months after reporting one case of evidence-free claims to Trading Standards (for an obesity remedy) under the Unfair Trading Regulations 2008,1 we have nothing but a case number and repeated requests to resend our complaint as it has been lost several times.

In another case we challenged the claims made for a widely marketed snoring remedy. The manufacturer refused to provide any evidence, claiming that, although clinical trials had been carried out, the results were commercially sensitive and confidential. Trading Standards agreed that the manufacturer was not obliged to release the information, assuring us instead that its officer was satisfied with the evidence he had been shown. We, however, received no assurance that he could distinguish a good clinical trial from a bad one. Perhaps pharmaceutical companies should try telling the Medicines and Healthcare Products Regulatory Agency that their clinical data are too commercially sensitive to be . . . [Full text of this article]

Leslie B Rose, clinical science consultant1, John Garrow, emeritus professor of human nutrition2

1 Pharmavision Consulting, Salisbury SP2 8NJ, 2 London

les@pharmavision-consulting.co.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

All about letters
Jane Smith
BMJ 2009 338: b23. [Extract] [Full Text]

Trading regulations and health foods
M E J Lean
BMJ 2008 337: a2408. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ